P. Nenclares

发表

Introducing Checkpoint Inhibitors Into the Curative Setting of Head and Neck Cancers: Lessons Learned, Future Considerations.

K. Harrington, M. S. St John, L. Dunn, 2022, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer

Robin L. Jones, M. Gerlinger, K. Harrington, 2020, European Journal of Cancer.

Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer

S. Bhide, A. Melcher, K. Harrington, 2020, Clinical Oncology.

On-treatment immune prognostic score for patients with relapsed and/or metastatic head and neck squamous cell carcinoma treated with immunotherapy

S. Bhide, A. Melcher, K. Harrington, 2021, Journal for ImmunoTherapy of Cancer.

CDK4/6 inhibition and dsRNA sensor agonism co-operate to enhance anti-cancer effects through ER stress and immune modulation of tumour cells

V. Roulstone, J. Kyula, R. Vile, 2022, bioRxiv.

Head and neck mucosal melanoma: The United Kingdom national guidelines.

K. Harrington, C. Kerawala, V. Paleri, 2020, European journal of cancer.

Impact of antibiotic use during curative treatment of locally advanced head and neck cancers with chemotherapy and radiotherapy.

A. Melcher, K. Harrington, C. Nutting, 2020, European journal of cancer.

Taste dysfunction following radiotherapy to the head and neck: A systematic review.

S. Bhide, K. Harrington, C. Nutting, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Harnessing radiotherapy-induced NK-cell activity by combining DNA damage–response inhibition and immune checkpoint blockade

J. Kyula, A. Melcher, K. Harrington, 2022, Journal for ImmunoTherapy of Cancer.

Overexpression of PIK3CA in head and neck squamous cell carcinoma is associated with poor outcome and activation of the YAP pathway.

J. Paramio, C. Ballestín, M. Dueñas, 2018, Oral oncology.

What is the role of the surgeon in the management of head and neck mucosal melanoma in the immunotherapy era?

K. Harrington, C. Kerawala, V. Paleri, 2021, Head & neck.

Management of Head and Neck Mucosal Melanoma.

K. Harrington, P. Nenclares, 2022, Oral and maxillofacial surgery clinics of North America.

Cancer cell – fibroblast crosstalk signature promotes macrophage recruitment via HB-EGF and stromal EGFR/MEK signalling

M. Cheang, C. Swanton, S. Bhide, 2023, bioRxiv.

FUME-TCRseq: Sensitive and accurate sequencing of the T-cell receptor from limited input of degraded RNA

S. Bhide, T. Graham, A. Baker, 2023, bioRxiv.

Spatially-resolved profiling of the T-cell receptor repertoire in archival clinical specimens using FUME-TCRseq

S. Bhide, T. Graham, A. Baker, 2023 .

T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies

S. Bhide, A. Sadanandam, A. Melcher, 2024, Frontiers in oncology.

Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent anti-PD-L1- and anti-NKG2A-based adjuvant immunotherapy

V. Roulstone, J. Kyula, M. Dillon, 2023, bioRxiv.

Combination of oncolytic Maraba virus with immune checkpoint blockade overcomes therapy resistance in an immunologically cold model of advanced melanoma with dysfunctional T-cell receptor signalling

V. Roulstone, J. Kyula, V. Jennings, 2024, bioRxiv.